Abstract
Background: One of the main advantages of neoadjuvant chemotherapy (NACT) for breast cancer (BC) is an early initiation of systemic control of disease. However, the effectiveness of NACT does not correlate with the result of standard micro-morphological regression (RG) analysis, thus disease is in some cases not well controlled or even progressed. The main aim was to categorize the micro-morphological markers of RG and the baseline characteristics of tumor that identify patients at high risk of NACT failure.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
